Editorial: Response and Resistance in Castration-Resistant Prostate Cancer

Renée de Leeuw; Qi Cao; Hung Ming Lam

doi:10.3389/fonc.2020.607298

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer

Renée de Leeuw, Qi Cao, Hung Ming Lam^*

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Article number	607298
Journal	Frontiers in Oncology
Volume	10
DOIs	https://doi.org/10.3389/fonc.2020.607298
State	Published - Oct 23 2020

Funding

We are grateful to all authors that contributed to this e-book. Funding. RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research. RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research.

Keywords

androgen deprivation therapy (ADT)
castration-resistant prostate cancer
neuroendocrine prostate cancer
new therapy
treatment resistance

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fonc.2020.607298

Cite this

@article{3ec512341dbe45e8b2c802df69772681,

title = "Editorial: Response and Resistance in Castration-Resistant Prostate Cancer",

keywords = "androgen deprivation therapy (ADT), castration-resistant prostate cancer, neuroendocrine prostate cancer, new therapy, treatment resistance",

author = "\{de Leeuw\}, Ren{\'e}e and Qi Cao and Lam, \{Hung Ming\}",

note = "Funding Information: We are grateful to all authors that contributed to this e-book. Funding. RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research. Funding Information: RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research.",

year = "2020",

month = oct,

day = "23",

doi = "10.3389/fonc.2020.607298",

language = "English (US)",

volume = "10",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial

T2 - Response and Resistance in Castration-Resistant Prostate Cancer

AU - de Leeuw, Renée

AU - Cao, Qi

AU - Lam, Hung Ming

N1 - Funding Information: We are grateful to all authors that contributed to this e-book. Funding. RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research. Funding Information: RdL was supported by AUA Research Scholar Award and Prostate Cancer Foundation Young Investigator Award; QC by DoD (W81XWH1710357 and W81XWH1910563), ACS (RSG1519201), NIH/NCI (R01CA208257 and Prostate SPORE P50CA180995), and Northwestern Univ. Polsky Urologic Cancer Institute; H-ML by NIH Prostate Cancer SPORE (P50CA97186), DoD Prostate Cancer Biorepository Network, and Institute of Prostate Cancer Research.

PY - 2020/10/23

Y1 - 2020/10/23

KW - androgen deprivation therapy (ADT)

KW - castration-resistant prostate cancer

KW - neuroendocrine prostate cancer

KW - new therapy

KW - treatment resistance

UR - http://www.scopus.com/inward/record.url?scp=85095596343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095596343&partnerID=8YFLogxK

U2 - 10.3389/fonc.2020.607298

DO - 10.3389/fonc.2020.607298

M3 - Editorial

C2 - 33194772

AN - SCOPUS:85095596343

SN - 2234-943X

VL - 10

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 607298

ER -

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this